According to Steady Medical's announcement, as of August 31, 2026, the company had repurchased a total of 8,046,762 shares through centralized bidding transactions, accounting for about 1.3803% of the company's total share capital. The highest transaction price was 31.00 yuan/share, the lowest transaction price was 26.87 yuan/share, and the transaction amount was 230 million yuan. The repurchase of shares is used to reduce registered capital. The upper limit of the repurchase price has been adjusted to no more than 47.21 yuan/share. The funding source is own funds and/or self-raised funds. The implementation period of the repurchase is within 12 months from the date the shareholders' meeting reviews and approves the repurchase plan. Subsequent companies will continue to implement the repurchase plan in line with market conditions.

According to Steady Medical's announcement, as of August 31, 2026, the company had repurchased a total of 8,046,762 shares through centralized bidding transactions, accounting for about 1.3803% of the company's total share capital. The highest transaction price was 31.00 yuan/share, the lowest transaction price was 26.87 yuan/share, and the transaction amount was 230 million yuan. The repurchase of shares is used to reduce registered capital. The upper limit of the repurchase price has been adjusted to no more than 47.21 yuan/share. The funding source is own funds and/or self-raised funds. The implementation period of the repurchase is within 12 months from the date the shareholders' meeting reviews and approves the repurchase plan. Subsequent companies will continue to implement the repurchase plan in line with market conditions.